by Jordana Choucair | May 31, 2022 | Life Sciences
Next week a key Food and Drug Administration (FDA) advisory committee will examine Novavax’s application for an emergency use authorization for its COVID-19 vaccine for adults 18 and older. Novavax originally planned to ask FDA for authorization by May 2021 but...
by Jordana Choucair | May 31, 2022 | Life Sciences
British drugmaker GSK PLC will buy vaccine manufacturer Affinivax Inc. for up to $3.3 billion, giving it access to promising experimental vaccine technology that targets two dozen common diseases. A GSK executive said Affinivax’s technology could broaden...
by Jordana Choucair | May 31, 2022 | Payers
Health and Human Services (HHS) Secretary Xavier Becerra announced on Friday that the Centers for Medicare & Medicaid Services (CMS) will not lower Medicare premiums for adults 65 and over until 2023. The adjustment is intended to compensate for...
by Jordana Choucair | May 31, 2022 | Public Health/Prevention
The World Health Organization (WHO) characterized monkeypox as a “moderate” public health risk as the illness spreads to varying geographical locations. The WHO said that since May 26, a total of 257 laboratory-confirmed cases have been reported across the globe....
by Jordana Choucair | May 31, 2022 | Public Health/Prevention
The WHO said it will form a 14-person committee to better respond to global health crises. The group will convene twice annually and immediately after the agency declares any international public health emergencies in the future. The WHO’s executive board...
by Jordana Choucair | May 27, 2022 | Access & Coverage
The Centers for Medicare & Medicaid Services (CMS) approved four additional states to expand Medicaid and Children’s Health Insurance Program (CHIP) coverage to up to a year postpartum. Florida, California, Oregon, and Kentucky join a list of seven other states...
Recent Comments